Cirrhosis of liver: Etiological factors, complications and prognosis

Journal of the Liaquat University of Medical and Health Sciences

Volumn 7, Issue 2, 2008, Pages 61-66

  Almani, Suhail Ahmed ^a   Memon, A Sattar ^a   Memon, Amir Iqbal ^a   Shah, M Iqbal ^a   Rahpoto, M Qasim ^a   Solangi, Rahim ^a  

^a LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Pakistan)

Author keywords

Ascites; Cirrhosis; HCV infection; Liver; Viral hepatitis

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; ASCITES; BACTERIAL PERITONITIS; DISEASE CLASSIFICATION; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMATEMESIS; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PAKISTAN; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; RISK FACTOR; WILSON DISEASE;

EID: 51649095088     PISSN: 17290341     EISSN: None     Source Type: Journal    
DOI: 10.22442/jlumhs.08720145     Document Type: Article

References (38)

1. Gildea TR, Cook WC, Nelson DR, Aggarwal A, Carey W, Younossi ZM. Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Am Coll Chest Physicians. 2004;126:1598-603.
2. Runyon BA, Testa M. Hepatitis B and C. Am J Gastroenterol. 1999; 16: 835-40.
3. Maddrey WC. Update in hepatology. Ann Intern Med. 2001 ;13(4):216-23.
4. Khan AA. Endemic transmission of hepatitis C. J Coll Physicians Surg Pak. 1995; 5(1):11-3.
5. Nadeem MA, Waseem T, Sheikh AM, Grumman N, Irfan K, Hasnain SS. Hepatitis C virus: An alarmingly increasing cause of liver cirrhosis in Pakistan. Pak J Gastroenterol. 2002; 16(1):3-8.
6. Naheed T. Antigenemia in chronic liver disease. Specialist (Pak J Med Sci) 1998; 14(4): 303-8.
7. Hussain I, Nasrullah M, Shah AA. Prevalence of hepatitis B and C viral infections in liver cirrhosis in Pakistan. Pak J Gastroenterol 1998;12(1-2):7-11.
8. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Quraishi AH, Hussain A. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc. 2003; 53:136-40.
9. Farooqi JA, Khan PM. Viral aetiology of liver cirrhosis patients in Swat. Pak J Gastroenterol. 2002;16(2):39-42.
10. Khan TS, Rizvi F, Rashid A. Hepatitis C seropositivity among chronic liver disease patients in Hazara, Pakistan. J Ayub Med Coll Abbottabad. 2003;15: 53-5.
11. Dib N, Oberti F, Cales P. Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ. 2006; 174: 1433-43.
12. Gines P, Cardenas A, Arroyo V. Management of cirrhosis and ascites. N Engl J Med. 2004: 350-61.
13. Maqsood S, Saleem A, Iqbal A. Precipitating factors of hepatic encephalopathy. J Ayub Med Coll Abbottabad. 2006; 18.
14. Yan GZ, Duan YY, Ruan LT, Cao TS, Yuan LJ, Yang YL. Non-invasive quantitative testing of liver function using ultrasonography in patients with cirrhosis. Hepatogastroentrology. 2006;53:15-20.
15. Anslo P, Brinton LA, Nyren O. Viral hepatitis and cirrhosis. N Engl J Med. 1996;13:203-6.
16. Shah HA, Jafri W, Malik I, Prescott L, Simmonds P. Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol. 1997; 12:758-61.
17. D'Amico G, Morabito A, Pagliaro L. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986; 31:468-75.
18. Gines P, Quintero E, Arroyo V. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122-8.
19. Pagliaro L, D'Amico G, Pasta L. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann R, eds. Portal hypertension: pathophysiology and treatment. Cambridge, MA: Black-well Scientific, 1994:72-92.
20. Sherlock S. Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology. 1959; 37:574-86.
21. Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990;11:458-64.
22. Myszor M, James OF. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q J Med. 1990;75:377-85.
23. Metcalf JV, Bhopal RS, Scott LMD, Gray J, Howel D, James OFW. Temporal and geographical variations in the prevalence of primary biliary cirrhosis (PBC) in a stable population. Hepatology. 1995;22:384A.
24. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 71:139-64, 1992.
25. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH Jr., Ed. Major problems in internal medicine. Philadelphia: WB Saunders Company, Vol 23, 1984.
26. Schilsky ML. Wilson disease: genetic basis of copper toxicity and natural history. Sem Liver Dis. 1996; 16:83-95.
27. Hui AY, Chan HL, Leung NW. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol. 2002; 34: 569-72.
28. Ascites. In: Sherlock S, Dooley J eds. Diseases of the liver and biliary system.11 ed. Oxford, Black-well Science, 2002; 127-46.
29. Fernandez J, Navasa M, Gomez J. Bacterial Infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002; 35:140-48.
30. Iqbal M, Jamal S, Rathore OI, Qureshi MA. SBP in hospitalized chronic liver disease patients. JMMC.1997; 1:2-5.
31. Jaffary W, Shah, Hamid S. Spontaneous bacterial peritonitis. Specialist. 1992; 8: 33-8.
32. Graham D, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981; 80: 800-9.
33. Jenkins SA, Shields R, Davies M, et al. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut. 1997; 41: 526-33.
34. th edition. Philadelphia: WB Saunders. 1995; 1988-2003.
35. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 1998; 27: 273-8.
36. Tanaka R, Itoshima T, Nagashima H. Follow-up study of 582 liver cirrhosis patients for 26 yeras in Japan. Liver. 1987; 7:316-24.
37. Arroyo V, Ginès P, Gerbes A, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996; 23:164-76.
38. Daniel B, Fundakowski CE, Lisker-Melman M, Crippin JS, Pilgram TK, Chapman W, et al. Comparsion of MELD ans Child-Pugh scores to predict survival after chemoembolization for henatocellular carcinoma. J Vascular Interventional Radiol. 2004; 15:1209-18.